Pall India Pvt. Ltd., recently inaugurated its expanded Scientific Laboratory Services (SLS) Technical Support Center in Bangalore, which now has more than 60 per cent enhanced validation and testing capacity. Established in 2006, expansion of this SLS Technical Support center further enhances Pall's capability to support the process development needs of its customers across various industries. The move also reinforces Pall Corporation's dedication to the growing bio-pharmaceutical industry in India.
"Investment in this SLS Technical Support center to establish a premier filter validation facility represents a strong commitment from Pall Corporation towards solving the diverse and complex filtration and separation challenges of our customers in the South Asia region. It caters to both Life Sciences and Industrial businesses, providing our customers with advanced scientific support for their application needs. The expanded facility also houses a state-of-the-art training center," said Naresh Narasimhan, Managing Director, Pall India.
The Pall India SLS Technical Support center offers customized solutions through Pall products and technologies, filtration and validation packages, and optimization of customer applications and processes. This expanded facility provides a validated clean room for microbiology, a validated lab capable of handling cytotoxic materials, a unique validated cold room to facilitate low temperature testing and houses new technologies for protein purification and characterization.
Sachin Indane, Director of the Bio-pharmaceuticals division of Pall India, further emphasized, "With an increasing number of Indian pharmaceutical companies venturing into regulated markets, a need for reliable and speedy support in validation studies is eminent. We are very excited to pledge our support to the growing needs of this industry."
In addition, the SLS Technical Support center is focused on providing customers with wet laboratory training using specialized resources in the fields of filtration, biotech and vaccine process development, protein purification, process characterization and optimization. Training courses are fully customizable to Pall's offering in primary separation, sterilizing filtration of liquids and gases, tangential flow filtration and ultra-filtration, chromatography, filtration validation studies and regulatory requirements, filter integrity testing and single-use systems.
To celebrate the launch, Pall hosted senior industry leaders for a symposium on "Current Regulations and Inspection Trends for Filtration and Filling in Aseptic Processing", which was led by Jerold Martin, Sr. Vice President for Global Scientific Affairs, Pall Corporation.
Pall Corporation (NYSE:PLL), headquartered in Port Washington, New York, USA, is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across life sciences and industry. Pall Life Sciences provides products and services to meet the needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals.